文献速递肿瘤 PET/CT

淋巴结与原发肿瘤标准化摄取比值在子宫内膜样子宫内膜癌中的预后价值

Prognostic value of lymph node-to-primary tumor standardized uptake value ratio in endometrioid endometrial carcinoma.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-08-21

回顾性分析107例子宫内膜样子宫内膜癌患者术前[18F]FDG PET/CT资料,中位术后随访23个月(范围6-60),7例(6.5%)复发。回归分析显示SUVLN/SUVTumor(P<0.001)、SUVLN(P=0.003)、FIGO分期(P=0.006)和肿瘤分级(P=0.011)是复发危险因素,多因素分析仅FIGO分期(P=0.034)为独立危险因素。SUVLN/SUVTumor与FIGO分期、淋巴结转移、淋巴血管间隙浸润、复发、肿瘤分级及深肌层浸润显著相关,按SUVLN/SUVTumor分组患者无进展生存期差异显著(Log-rank检验,P=0.001)。

要点

  • 术前[18F]FDG PET/CT测量的SUVLN/SUVTumor与子宫内膜样子宫内膜癌复发显著相关。
  • SUVLN/SUVTumor与FIGO分期、淋巴结转移、淋巴血管间隙浸润、复发、肿瘤分级及深肌层浸润显著相关。
  • 按SUVLN/SUVTumor分组患者无进展生存期差异显著(Log-rank检验,P=0.001)。

核心结论

  • 术前[18F]FDG PET/CT测量的SUVLN/SUVTumor与复发显著相关,可能成为子宫内膜样子宫内膜癌的新预后因素。

研究设计与样本

  • 回顾性分析107例接受术前[18F]FDG PET/CT检查的子宫内膜样子宫内膜癌患者。
  • 评估PET/CT代谢变量(SUVTumor、SUVLN及SUVLN/SUVTumor)的预后价值。
  • 中位术后随访23个月(范围6-60),7例(6.5%)患者复发。

主要发现

  • 回归分析显示SUVLN/SUVTumor(P<0.001)、SUVLN(P=0.003)、FIGO分期(P=0.006)和肿瘤分级(P=0.011)是复发危险因素。
  • 多因素回归分析显示FIGO分期(P=0.034)是复发的独立危险因素。
  • SUVLN/SUVTumor与FIGO分期(P<0.001)、淋巴结转移(P<0.001)、淋巴血管间隙浸润(P<0.001)、复发(P=0.001)、肿瘤分级(P<0.001)及深肌层浸润(P=0.022)显著相关。
  • 按SUVLN/SUVTumor分组患者无进展生存期差异显著(Log-rank检验,P=0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine whether the relative metabolic activity of pelvic or para-aortic LN compared with that of primary tumor measured by preoperative [18F]FDG PET/CT scan has prognostic value in patients with endometrioid endometrial carcinoma. METHODS: We retrospectively reviewed patients with endometrioid endometrial carcinoma who underwent preoperative [18F]FDG PET/CT scans. Prognostic values of PET/CT-derived metabolic variables such as maximum standardized uptake value (SUV) of the primary endometrial carcinoma (SUVTumor) and LN (SUVLN), and the LN-to-endometrial carcinoma SUV ratio (SUVLN / SUVTumor) were assessed. RESULTS: Clinico-pathological data, imaging data, and treatment results were reviewed for 107 eligible patients. Median post-surgical follow-up was 23 months (range, 6-60), and 7 (6.5%) patients experienced recurrence. Regression analysis showed that SUVLN / SUVTumor (P < 0.001), SUVLN (P = 0.003), International Federation of Gynecology and Obstetrics (FIGO) stage (P = 0.006), and tumor grade (P = 0.011) were risk factors of recurrence. Multivariate regression analysis revealed that FIGO stage (P = 0.034) was the independent risk factor of recurrence. SUVLN / SUVTumor showed significant correlation with FIGO stage (P < 0.001), LN metastasis (P < 0.001), lymphovascular space invasion (P < 0.001), recurrence (P = 0.001), tumor grade (P < 0.001), and deep myometrial invasion of tumor (P = 0.022). Patient groups categorized by SUVLN / SUVTumor showed significant difference in progression-free survival (Log-rank test, P = 0.001). CONCLUSIONS: Preoperative SUVLN / SUVTumor measured by [18F]FDG PET/CT was significantly associated with recurrence, and may become a novel prognostic factor in patients with endometrioid endometrial carcinoma.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Chung HH, Cheon GJ, Kim JW, et al. Prognostic value of lymph node-to-primary tumor standardized uptake value ratio in endometrioid endometrial carcinoma. Eur J Nucl Med Mol Imaging. 2017. PMID: 28828510. doi:10.1007/s00259-017-3805-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。